INDP Indaptus Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 13, 2026
$2,38
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$0,92rendah 52m
$5,96tinggi 52m
Kapitalisasi Pasar (MRQ)
$317M
P/E
-0.1
EPS
$-21.58
lencana Anda
Rentang 52M
$1–$6
Peringkat Analis
BUY
Target Harga
$10
P/E
-0.1
ROE
-2820.8%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
INDP Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$2.38
Kapitalisasi Pasar (MRQ)
$317M
P/E
-0.1
EPS
$-21.58
ROE
-2820.8%
Rentang 52M
$1–$6
INDP Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 27 Juni 2025 | 1-for-28 | Terbalik |
| 27 Juli 2021 | 1-for-4 | Terbalik |
| 30 Okt. 2020 | 1-for-20 | Terbalik |
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
EPS$-21.582022-12-31 → 2025-12-31
Arus Kas Bebas·2021-12-31 → 2021-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | INDP | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -0.1rata-rata 5T ≈-12.8 | ≈-12.8 | · | · | |
| P/B (MRQ) | 27.9rata-rata 5T ≈31.7 | ≈31.7 | 2.4 | Terlalu mahal | |
| Price / Cash Flow (Harga / Arus Kas) | -0.3rata-rata 5T ≈-39.4 | ≈-39.4 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 1.6rata-rata 5T ≈31.7 | ≈31.7 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | INDP | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -250.5%rata-rata 5T ≈-107.1% | ≈-107.1% | -31.5% | Lemah | |
| ROE | -2820.8%rata-rata 5T ≈-662.2% | ≈-662.2% | -57.1% | Lemah | |
| ROIC | -629.4% | · | -55.3% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | INDP | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Current Ratio (Rasio Lancar) | 1.5rata-rata 5T ≈5.0 | ≈5.0 | 5.8 | Likuiditas rendah | |
| Quick Ratio (Rasio Cepat) | 1.4rata-rata 5T ≈4.8 | ≈4.8 | 3.3 | Di bawah rata-rata |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-5.4%
Laporan Berikutnya
Nov 10, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 31 Des. 2025 | $-4.51 | $-4.45 | -1.4% | |
| 30 Sep. 2025 | $-2.98 | $-4.25 | 29.9% | |
| 30 Juni 2025 | $-9.09 | $-9.42 | 3.6% | |
| 31 Maret 2025 | $-8.96 | $-5.14 | -74.3% | |
| 31 Des. 2024 | $-10.64 | $-12.57 | 15.3% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $9M | $7M | $8M | $6M | $3M | $3M | |
| SG&A Expense | $10M | $8M | $9M | $9M | $5M | $944.2K | |
| Operating Expenses | $20M | $15M | $16M | $15M | $8M | $4M | |
| Operating Income | $-20M | $-15M | $-16M | $-15M | $-8M | $-4M | |
| Other Non-op | · | $343.7K | $955.0K | $588.1K | $17.7K | $15.1K | |
| Pretax Income | $-21M | $-15M | · | · | · | · | |
| Income Tax | $1.7K | $1.7K | $2.5K | $30 | $1.6K | $800 | |
| Net Income | $-21M | $-15M | $-15M | $-14M | $-8M | $-4M | |
| EPS (Basic) | $-21.58 | $-44.96 | $-1.83 | $-1.73 | $-1.89 | · | |
| EPS (Diluted) | $-21.58 | $-44.96 | $-1.83 | $-1.73 | · | · | |
| Shares (Basic) | 966,124 | 334,133 | 8,401,047 | 8,262,119 | 4,090,599 | · | |
| Shares (Diluted) | 966,124 | 334,133 | 8,401,047 | 8,262,119 | · | · | |
| EBITDA | $-20M | $-15M | $-16M | $-15M | $-8M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $6M | $13M | $10M | $39M | $2M | |
| Short-term Investments | · | · | · | $17M | · | · | |
| Prepaid Expense | $802.5K | $831.6K | $633.2K | $811.4K | $1M | $94.5K | |
| Current Assets | $9M | $7M | $14M | $27M | $40M | $2M | |
| PP&E (Net) | · | · | $735 | $2.0K | $3.8K | $1.3K | |
| Other Non-current Assets | · | $638.3K | $754.7K | $738.3K | $16.5K | $44.4K | |
| Total Assets | $9M | $7M | $15M | $28M | $41M | $2M | |
| Accounts Payable | $544.1K | $870.2K | $806.0K | $1M | $3M | $156.0K | |
| Accrued Liabilities | · | · | · | · | · | $3M | |
| Current Liabilities | $6M | $3M | $3M | $3M | $5M | $2M | |
| Capital Leases | · | · | $73.3K | · | $72.9K | · | |
| Other Non-current Liabilities | · | · | · | · | · | $691.0K | |
| Total Liabilities | $6M | $3M | $3M | $3M | $5M | $2M | |
| Common Stock | $21.7K | $4.3K | $84.0K | $84.0K | $82.6K | $19.4K | |
| Paid-in Capital | $84M | $64M | $57M | $54M | $51M | $8M | |
| Retained Earnings | $-81M | $-60M | $-45M | $-30M | $-16M | $-8M | |
| AOCI | · | · | · | $96.4K | · | · | |
| Stockholders' Equity | $3M | $4M | $12M | $25M | $36M | $-237.7K | |
| Liabilities + Equity | $9M | $7M | $15M | $28M | $41M | $2M | |
| Shares Outstanding | 2,167,324 | 428,799 | 8,401,047 | 8,401,047 | 8,258,597 | 1,944,672 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $2M | $3M | $3M | $2M | $140.0K | |
| Operating Cash Flow | $-15M | $-12M | $-13M | $-13M | $-11M | $-3M | |
| CapEx | · | · | · | · | $3.9K | · | |
| Investing Cash Flow | · | · | $17M | $-16M | $447.7K | · | |
| Stock Issued | $6M | $6M | · | · | · | · | |
| Net Stock Activity | $6M | $6M | · | · | · | · | |
| Financing Cash Flow | $18M | $5M | · | · | $48M | $1M | |
| Taxes Paid | · | $1.6K | $1.6K | $2.4K | $800 | · | |
| Free Cash Flow | · | · | · | · | $-11M | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -250.5% | -134.9% | -71.8% | -41.7% | -36.4% | · | |
| ROE | -2820.8% | -302.0% | -112.5% | -54.9% | -20.8% | · | |
| ROIC | -629.4% | · | · | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 2.0 | 5.0 | 7.9 | 8.8 | · | |
| Quick Ratio | 1.4 | 1.7 | 4.8 | 7.7 | 8.5 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.45 | $0.33 | $1.44 | $2.93 | $4.35 | · | |
| Cash Flow / Share | $-15.34 | $-1.32 | $-1.60 | · | · | · | |
| Cash / Share | $3.93 | $0.48 | $1.59 | $1.15 | $4.74 | · | |
| EPS (TTM) | $-21.58 | $-44.96 | $-1.83 | $-1.73 | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-21M | $-15M | $-15M | $-14M | $-8M | · | |
| Market Cap | $6M | $283M | $414M | $341M | $1.32B | · | |
| P/E | -0.1 | -0.5 | -26.9 | -23.5 | · | · | |
| P/B | 2.0 | 71.8 | 34.3 | 13.8 | 36.7 | · | |
| P / Tangible Book | 2.0 | 71.8 | 34.3 | 13.8 | 36.7 | · | |
| P / Cash Flow | -0.4 | -23.0 | -30.9 | -26.1 | -116.7 | · | |
| P / FCF | · | · | · | · | -116.7 | · | |
| Earnings Yield | -741.6% | -190.7% | -3.7% | -4.3% | · | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $363.1K | $491.1K | $3M | $2M | $2M | $3M | $2M | $1M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | |
| SG&A Expense | $1M | $2M | $5M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | |
| Operating Expenses | $2M | $2M | $8M | $3M | $4M | $5M | $4M | $3M | $4M | $4M | $4M | $4M | $3M | $4M | $4M | $4M | |
| Operating Income | $-2M | $-2M | $-8M | $-3M | $-4M | $-5M | $-4M | $-3M | $-4M | $-4M | $-4M | $-4M | $-3M | $-4M | $-4M | $-4M | |
| Other Non-op | $14.0K | $-381.5K | · | · | $-772.2K | $40.1K | · | $73.0K | $93.6K | $136.6K | $176.9K | $326.0K | $250.2K | $201.9K | $431.2K | $86.2K | |
| Net Income | $-2M | $-3M | $-8M | $-3M | $-5M | $-5M | $-4M | $-3M | $-4M | $-4M | $-4M | $-4M | $-3M | $-4M | $-4M | $-3M | |
| EPS (Basic) | $-0.02 | $-0.23 | $-9.19 | $-2.98 | $-9.09 | $-9.11 | $-22.31 | $-9.04 | $-13.16 | $-0.45 | $-0.46 | $-0.47 | $-0.39 | $-0.51 | $-0.44 | $-0.42 | |
| EPS (Diluted) | $-0.02 | $-0.23 | $-9.19 | $-2.98 | $-9.09 | $-9.11 | $-22.31 | $-9.04 | $-13.16 | $-0.45 | $-0.46 | $-0.47 | $-0.39 | $-0.51 | $-0.44 | $-0.42 | |
| Shares (Basic) | 116,131,213 | 10,956,650 | · | 997,038 | 574,923 | 497,794 | · | 339,659 | 305,140 | 8,442,364 | · | 8,401,047 | 8,401,047 | 8,401,047 | · | 8,258,597 | |
| Shares (Diluted) | 116,131,213 | 10,956,650 | · | 997,038 | 574,923 | 497,794 | · | 339,659 | 305,140 | 8,442,364 | · | 8,401,047 | 8,401,047 | 8,401,047 | · | 8,258,597 | |
| EBITDA | $-2M | $-2M | · | $-3M | $-4M | $-5M | · | $-3M | $-4M | $-4M | · | $-4M | $-3M | $-4M | · | $-4M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $1M | $9M | $6M | $6M | $4M | $6M | $7M | $7M | $10M | $13M | $16M | $13M | $7M | $10M | $7M | |
| Short-term Investments | $4M | · | · | · | · | · | · | · | · | · | · | · | $7M | $15M | $17M | $22M | |
| Prepaid Expense | $434.1K | $683.2K | $802.5K | $613.4K | $255.4K | $1M | $831.6K | $248.7K | $186.7K | $551.0K | $633.2K | $879.5K | $180.8K | $470.8K | $811.4K | $1M | |
| Other Current Assets | $27.8K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | · | $2M | $9M | $6M | $6M | $5M | $7M | $8M | $7M | $10M | $14M | $17M | $20M | $22M | $27M | $30M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | $735 | $1.1K | $1.4K | $1.7K | $2.0K | $2.3K | |
| Other Non-current Assets | · | · | · | $392.6K | $392.6K | $392.6K | $638.3K | $504.7K | $504.7K | $504.7K | $754.7K | $754.7K | $754.7K | $754.7K | $738.3K | $754.7K | |
| Total Assets | $12M | · | $9M | $7M | $7M | $5M | $7M | $8M | $8M | $11M | $15M | $18M | $21M | $23M | $28M | $30M | |
| Accounts Payable | $508.9K | $557.4K | $544.1K | $707.4K | $618.5K | $1M | $870.2K | $555.9K | $416.6K | $405.5K | $806.0K | $617.3K | $747.7K | $382.1K | $1M | $1M | |
| Current Liabilities | · | $933.0K | $6M | $2M | $9M | $3M | $3M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $3M | $3M | |
| Capital Leases | · | · | · | · | · | · | · | $4.0K | $27.6K | $50.7K | $73.3K | $95.2K | $116.2K | $136.7K | · | $4.9K | |
| Total Liabilities | $615.4K | · | · | · | · | · | · | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $3M | $3M | |
| Common Stock | $1M | $1M | $21.7K | $16.4K | $6.0K | $160.3K | $4.3K | $102.0K | $85.5K | $85.4K | $84.0K | $84.0K | $84.0K | $84.0K | $84.0K | $82.6K | |
| Paid-in Capital | $96M | $84M | $84M | $78M | $69M | $68M | $64M | $62M | $59M | $58M | $57M | $57M | $56M | $55M | $54M | $54M | |
| Retained Earnings | $-86M | $-84M | $-81M | $-73M | $-70M | $-65M | $-60M | $-56M | $-53M | $-49M | $-45M | $-41M | $-37M | $-34M | $-30M | $-26M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | · | $134.2K | $177.5K | $96.4K | $15.1K | |
| Stockholders' Equity | $11M | $1M | $3M | $5M | $-2M | $3M | $4M | $6M | $6M | $9M | $12M | $15M | $19M | $21M | $25M | $28M | |
| Liabilities + Equity | $12M | $2M | $9M | $7M | $7M | $5M | $7M | $8M | $8M | $11M | $15M | $18M | $21M | $23M | $28M | $30M | |
| Shares Outstanding | 133,242,324 | 113,242,324 | 2,167,324 | 1,641,920 | 604,963 | 16,034,444 | 428,799 | 10,196,884 | 8,553,047 | 8,538,883 | 8,401,047 | 8,401,047 | 8,401,047 | 8,401,047 | 8,401,047 | 8,258,597 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $-64.3K | $227.2K | $785.8K | $150.6K | $180.8K | $240.9K | $304.1K | $444.2K | $782.9K | $774.7K | $745.5K | $764.8K | $728.5K | $727.1K | $637.6K | $584.0K | |
| Operating Cash Flow | $-2M | $-7M | $-3M | $-3M | $-4M | $-5M | $-3M | $-3M | $-2M | $-4M | $-3M | $-4M | $-2M | $-5M | $-2M | $-5M | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | · | $0 | $7M | $8M | $2M | $5M | $-3M | |
| Stock Issued | · | · | $0 | $2M | $575.1K | $3M | $2M | $3M | $39.5K | $336.0K | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $3M | · | · | · | $336.0K | · | · | · | · | · | · | |
| Financing Cash Flow | · | · | $6M | $2M | $6M | $3M | $2M | $3M | $38.1K | $316.0K | · | · | · | · | · | · | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -19.1% | · | · | -39.5% | -69.9% | -55.4% | · | -23.6% | -27.7% | -22.3% | · | -16.3% | -11.8% | -14.1% | · | -9.3% | |
| ROE | -37.0% | -125.6% | · | -56.1% | -232.8% | -74.5% | · | -28.8% | -32.4% | -24.9% | · | -18.3% | -13.2% | -15.6% | · | -10.6% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.3 | · | 2.9 | 0.8 | 1.9 | · | 3.4 | 3.9 | 6.7 | · | 7.1 | 9.4 | 12.2 | · | 10.3 | |
| Quick Ratio | · | 1.6 | · | 2.6 | 0.7 | 1.5 | · | 3.3 | 3.8 | 6.3 | · | 6.7 | 9.4 | 11.9 | · | 9.9 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.09 | $0.01 | · | $2.81 | $-2.77 | $0.17 | · | $0.59 | $0.72 | $1.10 | · | $1.83 | $2.22 | $2.52 | · | $3.34 | |
| Cash Flow / Share | · | $-0.64 | · | · | · | $-0.36 | · | · | · | $-0.47 | · | · | · | · | · | · | |
| Cash / Share | $0.06 | $0.01 | · | $3.55 | $10.18 | $0.24 | · | $0.72 | $0.85 | $1.14 | · | $1.90 | $1.51 | $0.81 | · | $0.81 | |
| EPS (TTM) | $-12.42 | $-21.49 | · | $-43.49 | $-49.55 | $-53.62 | · | $-23.11 | $-14.54 | $-1.77 | · | $-1.81 | $-1.76 | $-1.83 | · | · |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-15M | $-19M | · | $-17M | $-17M | $-16M | · | $-15M | $-16M | $-15M | · | $-15M | $-15M | $-15M | · | $-14M | |
| Market Cap | $400M | $206M | · | $5M | $6M | $247M | · | $354M | $508M | $536M | · | $648M | $449M | $435M | · | $499M | |
| P/E | -0.2 | -0.1 | · | -0.1 | -0.2 | -0.3 | · | -1.5 | -4.1 | -35.4 | · | -42.6 | -30.4 | -28.3 | · | · | |
| P/B | 35.1 | 165.2 | · | 1.0 | -3.8 | 88.2 | · | 59.0 | 82.3 | 57.2 | · | 42.3 | 24.1 | 20.5 | · | 18.1 | |
| P / Tangible Book | 35.1 | 165.2 | · | 1.0 | · | 88.2 | · | 59.0 | 82.3 | 57.2 | · | 42.3 | 24.1 | 20.5 | · | 18.1 | |
| P / Cash Flow | · | -29.4 | · | · | · | -48.9 | · | · | · | -136.1 | · | · | · | -87.7 | · | · | |
| Earnings Yield | -414.0% | -1180.8% | · | -1515.3% | -470.6% | -348.2% | · | -66.6% | -24.5% | -2.8% | · | -2.4% | -3.3% | -3.5% | · | · |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Laba Bersih | $-21M | $-15M | $-15M | $-14M | $-8M |
| EPS Dilusian | $-21.58 | $-44.96 | $-1.83 | $-1.73 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 1.5 | 2.0 | 5.0 | 7.9 | 8.8 |
| Rasio Cepat | 1.4 | 1.7 | 4.8 | 7.7 | 8.5 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | · | · | · | · | $-11M |
Pemilik institusional (13F) 10 pengaju · $537K total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
10
Nilai yang dipegang
$537K
Posisi baru
6
Posisi yang keluar
2
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 6 (+2 vs Kuartal sebelumnya) | 2 (0 vs Kuartal sebelumnya) | 2 (+2 vs Kuartal sebelumnya) | 0 (-1 vs Kuartal sebelumnya) | +314K |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | $169.410 | 56.470 | 31,53% | Saham |
| JANE STREET GROUP, LLC | $161.433 | 53.811 | 30,04% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $100.956 | 33.652 | 18,79% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $41.901 | 13.967 | 7,80% | Saham |
| MILLENNIUM MANAGEMENT LLC | $34.758 | 11.586 | 6,47% | Saham |
| MORGAN STANLEY | $26.808 | 8.936 | 4,99% | Saham |
| UBS Group AG | $1.434 | 478 | 0,27% | Saham |
| HRT FINANCIAL LP | $618 | 206.077 | 0,12% | Saham |
| SBI Securities Co., Ltd. | $51 | 17 | 0,01% | Saham |
| CWM, LLC | $4 | 2 | 0,00% | Saham |
Aktivis & pemilik 5%+ 11 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Yang Ting | 26 Juni 2026 | 8,44% | Amandemen | · | SEC |
| Sino Lion Ventures Ltd, Chenhao Xu | 26 Juni 2026 | 29,19% | Amandemen | · | SEC |
| Yao Yun ×3 pengajuan | 26 Juni 2026 | 31,51% | Amandemen | · | SEC |
| Dai Junyi | 26 Juni 2026 | 8,44% | Amandemen | · | SEC |
| Lazar David E. ×2 pengajuan | 24 Maret 2026 | 47,93% | Amandemen | · | SEC |
| Jeffery A. Meckler | 30 Des. 2025 | 12,70% | Amandemen | · | SEC |
| Newman Michael James | 30 Des. 2025 | 5,40% | Amandemen | · | SEC |
| Jeffrey A. Meckler ×2 pengajuan | 26 Nov. 2024 | · | Pengajuan awal | · | SEC |
| Glen R. Anderson ×3 pengajuan | 17 Nov. 2021 | · | Pengajuan awal | · | SEC |
| Hoonmo Lee, TY Bio Investments, Inc. ×2 pengajuan | 26 Okt. 2021 | · | Pengajuan awal | · | SEC |
| Michael J. Newman, Ph.D. ×2 pengajuan | 26 Okt. 2021 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 19 orang dalam · 6 pejabat · 14 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Jeffery A. Meckler | Co-Chief Executive Officer | 11 Feb. 2026 A | 229.929 | 0 | 0 | $0 |
| Nir Sassi | Chief Financial Officer | 22 Des. 2025 A | 26.758 | 0 | 0 | $0 |
| Walt Addison Linscott | Chief Operating Officer | 22 Des. 2025 A | 54.426 | 0 | 0 | $0 |
| Newman Michael James | CSO and Director | 22 Des. 2025 A | 101.074 | 0 | 0 | $0 |
| Roger J. Waltzman | Chief Medical Officer | 9 Okt. 2024 A | · | 0 | 0 | $0 |
| Boyan Vesselinov Litchev | Chief Medical Officer | 1 Des. 2022 P | 1.150 | 0 | 0 | $0 |
| Lazar David E. | Direktur | 23 Maret 2026 S | · | 0 | 0 | $0 |
| Jerome D Jabbour | Direktur | 26 Feb. 2026 A | · | 0 | 0 | $0 |
| David Natan | Direktur | 7 Jan. 2026 A | · | 0 | 0 | $0 |
| Avraham Ben-Tzvi | Direktur | 23 Des. 2025 A | 25.100 | 0 | 0 | $0 |
| Mark John Gilbert | Direktur | 10 Juni 2025 A | · | 0 | 0 | $0 |
| Hila Karah | Direktur | 10 Juni 2025 A | · | 0 | 0 | $0 |
| Roger Pomerantz | Direktur | 10 Juni 2025 A | · | 0 | 0 | $0 |
| Anthony J Maddaluna | Direktur | 10 Juni 2025 A | · | 0 | 0 | $0 |
| Robert Martell | Direktur | 10 Juni 2025 A | · | 0 | 0 | $0 |
| William B Hayes | Direktur | 10 Juni 2025 A | · | 0 | 0 | $0 |
| Brian O'Callaghan | Direktur | 30 Sep. 2022 A | · | 0 | 0 | $0 |
| Hoonmo Lee | Direktur | 4 Agu 2021 A | · | 0 | 0 | $0 |
| Glen R. Anderson | Pemilik 10% | 14 Agu 2023 P | 1.190.400 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 1 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 33.652 SH | 19 Agu 2026 | Harian |
INDP Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 7 analis
BELI
Target median
$10.00
+320,2%
2 28,6%
Beli Kuat
4 57,1%
Beli
1 14,3%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
1 analis · 2026-05-01Target rata-rata $10.00 +320,2%
Rendah$10.00
Rata-rata$10.00
Tinggi$10.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| INDP | $6M | -0.1 | · | · | -2820.8% | · |
| IRD | $140M | -2.5 | 29.1% | -349.3% | -302.2% | · |
| AGEN | $111M | · | 10.4% | -2.7% | 1.0% | · |
| ENTA | $256M | -3.1 | -3.4% | -125.4% | -103.5% | · |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | · |
| FENC | $263M | -22.6 | -6.1% | -21.8% | -69.6% | · |
| ZNTL | $93M | -0.7 | · | · | -49.5% | · |
| SRZN | · | · | · | · | · | · |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | · |
| CYPH | $97M | 16.6 | · | · | 6.1% | · |
| ARTV | · | -1.3 | -99.2% | · | · | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 13, 2026